DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

DEVELOPMENTS

28 Drugs in Development

28 Drugs in Development

DIGITAL CONTENT

6 NEWS #PharmaBuzz

media
6 NEWS #PharmaBuzz

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

28DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: Androgen receptor-in-2, Masofaniten [inn], 2416716-62-4, Oq2sf7p8b2, N-(4-((4-(2-(3-chloro-4-(2-chloroethoxy)-5-cyanophenyl)propan-2-yl)phenoxy)methyl)pyrimidin-2-yl)methanesulfonamide, Methanesulfonamide, n-(4-((4-(1-(3-chloro-4-(2-chloroethoxy)-5-cyanophenyl)-1-methylethyl)phenoxy)methyl)-2-pyrimidinyl)-

Molecular Formula

C₂₄H₂₄Cl₂N₄O₄S

Molecular Weight

535.4 g/mol

InChI Key

GVCZSODXLFBYSS-UHFFFAOYSA-N

FDA UNII

OQ2SF7P8B2

1 2D Structure

Masofaniten

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

N-[4-[[4-[2-[3-chloro-4-(2-chloroethoxy)-5-cyanophenyl]propan-2-yl]phenoxy]methyl]pyrimidin-2-yl]methanesulfonamide

2.1.2 InChI

InChI=1S/C24H24Cl2N4O4S/c1-24(2,18-12-16(14-27)22(21(26)13-18)33-11-9-25)17-4-6-20(7-5-17)34-15-19-8-10-28-23(29-19)30-35(3,31)32/h4-8,10,12-13H,9,11,15H2,1-3H3,(H,28,29,30)

2.1.3 InChI Key

GVCZSODXLFBYSS-UHFFFAOYSA-N

2.1.4 Canonical SMILES

CC(C)(C1=CC=C(C=C1)OCC2=NC(=NC=C2)NS(=O)(=O)C)C3=CC(=C(C(=C3)Cl)OCCCl)C#N

2.2 Other Identifiers

2.2.1 UNII

OQ2SF7P8B2

2.3 Synonyms

2.3.1 Depositor-Supplied Synonyms

1. Androgen Receptor-in-2

2. Masofaniten [inn]

3. 2416716-62-4

4. Oq2sf7p8b2

5. N-(4-((4-(2-(3-chloro-4-(2-chloroethoxy)-5-cyanophenyl)propan-2-yl)phenoxy)methyl)pyrimidin-2-yl)methanesulfonamide

6. Methanesulfonamide, N-(4-((4-(1-(3-chloro-4-(2-chloroethoxy)-5-cyanophenyl)-1-methylethyl)phenoxy)methyl)-2-pyrimidinyl)-

7. Methanesulfonamide, N-[4-[[4-[1-[3-chloro-4-(2-chloroethoxy)-5-cyanophenyl]-1-methylethyl]phenoxy]methyl]-2-pyrimidinyl]-

8. N-(4-((4-(2-(3-chloro-4-(2-chloroethoxy)-5- Cyanophenyl)propan-2-yl)phenoxy)methyl)pyrimidin-2- Yl)methanesulfonamide

9. N-{4-[(4-{2-[3-chloro-4-(2-chloroethoxy)-5- Cyanophenyl]propan-2-yl}phenoxy)methyl]pyrimidin-2- Yl}methanesulfonamide

10. Masofaniten [usan]

11. Unii-oq2sf7p8b2

12. Chembl5095106

13. Schembl21854438

14. Epi7386

15. Epi-7386

16. Ms-29890

17. Hy-136582

18. Cs-0131867

19. F82723

2.4 Create Date

2020-06-27

3 Chemical and Physical Properties

Molecular Formula	C₂₄H₂₄Cl₂N₄O₄S
Molecular Weight	535.4 g/mol
XLogP3	4.7
Hydrogen Bond Donor Count	1
Hydrogen Bond Acceptor Count	8
Rotatable Bond Count	10
Exact Mass	g/mol
Monoisotopic Mass	g/mol
Topological Polar Surface Area	123
Heavy Atom Count	35
Formal Charge	0
Complexity	823
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1